Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Prepaid Assets (2019 - 2025)

IDEAYA Biosciences' Prepaid Assets history spans 7 years, with the latest figure at $21.4 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 59.52% year-over-year to $21.4 million; the TTM value through Dec 2025 reached $21.4 million, up 59.52%, while the annual FY2025 figure was $21.4 million, 59.52% up from the prior year.
  • Prepaid Assets for Q4 2025 was $21.4 million at IDEAYA Biosciences, up from $15.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $21.4 million in Q4 2025 and bottomed at $2.8 million in Q1 2022.
  • The 5-year median for Prepaid Assets is $7.1 million (2023), against an average of $8.6 million.
  • The largest annual shift saw Prepaid Assets decreased 23.48% in 2022 before it soared 162.84% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $3.1 million in 2021, then soared by 73.36% to $5.4 million in 2022, then soared by 38.53% to $7.5 million in 2023, then soared by 78.59% to $13.4 million in 2024, then soared by 59.52% to $21.4 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Prepaid Assets are $21.4 million (Q4 2025), $15.8 million (Q3 2025), and $15.9 million (Q2 2025).